Combination therapy for epilepsy;Kombinationstherapie bei Epilepsie

Fortschritte der Neurologie Psychiatrie

Volumn 81, Issue 1, 2013, Pages 9-20

  Froscher W ^a,b   Rosche J ^b  

^a Epilepsiezentrum Bodensee   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

antiepileptic drugs; combination therapy; epilepsy; monotherapy

Indexed keywords

ANTICONVULSIVE AGENT; HARKOSERIDE; LAMOTRIGINE; VALPROIC ACID;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; HUMAN; MONOTHERAPY;

ANTICONVULSANTS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; EPILEPSY; HUMANS; POLYPHARMACY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84872968298     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0031-1299361     Document Type: Article

References (159)

1. Kwan P., Brodie M. Combination therapy in epilepsy: when and what to use. Drugs: 2006; 66 1817 1829 (Pubitemid 44584005)
2. Reynolds E. H., Shorvon S. D. Monotherapy or polytherapy for epilepsy. Epilepsia: 1981; 22 1 10
3. Rote Liste 1971. Aulendorf/Württ Editio Cantor: 1971
4. Merlis J. K., Goldensohn E. S., Kramer M. D. et al. An international glossary of anticonvulsant and antiepileptic drugs. 3rd edition Quincy, Mass., USA International Bureau for Epilepsy: 1976
5. Schmidt D. Reduction of two-drug therapy in intractable epilepsy. Epilepsia: 1983; 24 368 376 (Pubitemid 13106557)
6. St Louis E. K. Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care. Current Neuropharmacol: 2009; 7 106 114
7. Commission on classification and terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia: 1981; 22 489 501
8. Commission on classification and terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia: 1989; 30 389 399
9. Berg A. T., Berkovic S. F., Brodie M. et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE commission on classification and terminology. Epilepsia: 2010; 51 676 685
10. Guelen P. JM, van der Kleijn E. Rational anti-epileptic drug therapy. Amsterdam Elsevier/North-Holland Biomedical Press: 1978
11. Deckers C. LP. Overtreatment in adults with epilepsy. Epilepsy Res: 2002; 52 43 52 (Pubitemid 35351531)
12. Majkowski J., Kacinski M., Jedrzejczak J. et al. Pharmacotherapy of epilepsy in Poland, 2000-2001. An analysis of a multi-centre prospective study of 6195 patients. Epileptologia: 2005; 13 11 27
13. St Louis E. K. Truly "rational" polytherapy: maximizing efficacy and minimizing drug interactions, drug load and adverse effects. Curr Neuropharmacol: 2009; 7 96 105
14. Cretin B., Hirsch E. Adjunctive antiepileptic drugs in adult epilepsy: How the first add-on could be the last. Expert Opin Pharmacother: 2010; 11 1053 1067
15. Johannessen Landmark C., Fossmark H., Larsson P. G. et al. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population. Epilepsy Res: 2011; 95 51 59
16. Gesellschaft für Datenverarbeitung mbH GKV-Daten, 12-Monatswert 06/2011. Karlsfeld: 25 10 2011
17. Bauer J. Antiepileptische Kombinationstherapie: Rationale Konzepte versus reelle Effektivität. Fortschr Neurol Psychiat: 1998; 66 414 426 (Pubitemid 28430780)
18. Fukushima K. Mono- or polytherapy and the severity of epilepsies. Jpn J Psychiatry Neurol: 1988; 42 483 487
19. Mattson R. H., Cramer J. A. Crossover from polytherapy to monotherapy in primary generalized epilepsy. Am J Med: 1988; 84 23 28
20. McDonald D. GM, Najam Y., Keegan M. B. et al. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood. Seizure: 2005; 14 112 116 (Pubitemid 40214737)
21. Stephen L. J., Brodie M. J. Selection of antiepileptic drugs in adults. Neurol Clin: 2009; 27 967 992
22. Mattson R. H. Drug treatment of partial epilepsy. Adv Neurol: 1992; 57 643 650
23. Kwan P., Brodie M. J. Early identification of refractory epilepsy. N Engl J Med: 2000; 342 314 319 (Pubitemid 30075244)
24. Mohanraj R., Brodie M. J. Diagnosing refractory epilepsy: Response to sequential treatment schedules. Eur J Neurol: 2006; 8 434 437
25. Hakkarainen H. Carbamazepine vs. diphenylhydantoin vs their combination in adult epilepsy. Neurology: 1980; 30 354
26. Brodie M. J., Yuen A. WG. 105 study group. Lamotrigine substitution study: Evidence for synergism with sodium valproate? Epilepsy Res: 1997; 26 423 432 (Pubitemid 27146300)
27. Pisani F., Oteri G., Russo M. F. et al. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: Evidence for a pharmacodynamic interaction. Epilepsia: 1999; 40 1141 1146 (Pubitemid 29372631)
28. Moeller J. J., Rahey S. R., Sadler R. M. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy. Epilepsia: 2009; 50 475 479
29. Chicharro A., Gaete G., Vargas P. et al. Focal refractory epilepsy: Should valproic acid-lamotrigine combination be tested previous to establishing diagnosis? Epilepsia: 2011; 52 06 155
30. Poolos N. P., Warner L. N., Humphrey S. et al. Comparative efficacy of combination drug therapy in refractory epilepsy. Epilepsia: 2011; 52 06 372
31. Belousova E. D., Shulyakova I. V., Ermakov A. Y. Effectiveness of valproate in combination with lamotrigine or topiramate or levetiracetam in children with drug resistant focal epilepsies: An open-label prospective observational study. Epileptologia: 2011; 19 123 129
32. Bauer J., Kronisch C. Medikamentöse Epilepsietherapie. Nervenarzt: 2009; 80 386 398
33. Callaghan B. C., Anand K., Hesdorffer D. et al. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol: 2007; 62 382 389 (Pubitemid 350105952)
34. Luciano A. L., Shorvon S. D. Results of treatment changes with apparently drug-resistant chronic epilepsy. Ann Neurol: 2007; 62 375 381 (Pubitemid 350105951)
35. Beyenburg S., Stavem K., Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia: 2010; 51 7 26
36. Deeks E. D. Retigabine (Ezogabine) in partial-onset seizures in adults with epilepsy. CNS Drugs: 2011; 25 887 900
37. Chung S., Sperling M. R., Biton V. et al. Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial. Epilepsia: 2010; 51 958 967
38. Anhut H., Ashman P., Feuerstein T. J. et al. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: A double-blind, placebo-controlled study. Epilepsia: 1994; 35 795 801 (Pubitemid 24278033)
39. Baulac M., Cavalcanti D., Semah F. et al. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. Seizure: 1998; 7 55 62 (Pubitemid 28121951)
40. Ben-Menachem E., Gabbai A. A., Hufnagel A. et al. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Epilepsy Res: 2010; 89 278 285
41. Beydoun A., Nasreddine W., Atweh S. Efficacy and tolerability of pregabalin in partial epilepsy. Expert Rev Neurother: 2008; 8 1013 1024 (Pubitemid 351962069)
42. Biton V., Krauss G., Vasquez-Santana B. et al. A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures. Epilepsia: 2011; 52 234 242
43. Brodie M. J., Duncan R., Vespignani H. et al. Dose-dependent safety and efficacy of zonisamide: A randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia: 2005; 46 31 41 (Pubitemid 40179930)
44. Brodie M. J., Lerche H., Gil-Nagel A. et al. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology: 2010; 75 1817 1824
45. Chahem J., Bauer J. Epilepsietherapie mit Antiepileptika der dritten Wahl. Nervenarzt: 2007; 78 1407 1412
46. French J. A., Abou-Khalil B. W., Leroy R. F. et al. Randomized double-blind placebo-controlled trial of ezogabine (retigabine) in partial epilepsy. Neurology: 2011; 76 1555 1563
47. Fröscher W. New antiepileptic drugs. Neurology, Psychiatry and Brain Res: 1999; 7 71 78 (Pubitemid 29508015)
48. Nadkarni S., LaJoie J., Devinsky O. Current treatment of epilepsy. Neurology: 2005; 64 03 S2 S11
49. Novy J., Patsalos P. N., Sander J. W. et al. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: A pharmacodynamic interaction? Epilepsy Behav: 2011; 20 20 23
50. Rosenfeld W. E., Benbadis S., Edrich P. et al. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: Analysis of two randomized, double-blind, placebo-controlled studies. Epilepsy Res: 2009; 85 72 80
51. Wellmer S., Wellmer J., Bauer J. Zonisamid zur Komedikation fokaler Epilepsien. Nervenarzt: 2008; 79 1416 1423
52. Czuczwar S. J., Borowicz K. K. Polytherapy in epilepsy: the experimental evidence. Epilepsy Res: 2002; 52 15 23 (Pubitemid 35351528)
53. Luszczki J. J., Andres M. M., Czuczwar P. et al. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis. Epilepsia: 2006; 47 10 20
54. Liedtke R. K. Wörterbuch der klinischen Pharmakologie. Stuttgart G Fischer: 1980
55. Fröscher W. Synergistic and additive effects of antiepileptic drugs in epileptic patients. In: Majkowski J., Owczarek K., Zwolinski P. (eds) 3rd European Congress of Epileptology. Bologna Monduzzi Editore: 1998; 387 393
56. Patsalos P. N., Fröscher W., Pisani F. et al. The importance of drug interactions in epilepsy therapy. Epilepsia: 2002; 43 365 368
57. Neher K. D. Interaktionen: Beeinflussung der Serum-Konzentration von Antiepileptika durch andere Medikamente. In: Fröscher W., Blankenhorn V., May T. W. et al. Pharmakotherapie der Epilepsien. Stuttgart Schattauer: 2008; 135 177
58. Rowan A. J., Meijer J. WA, de Beer-Pawlikowski N. et al. Valproate - ethosuximide combination therapy for refractory absence seizures. Arch Neurol: 1983; 40 797 802 (Pubitemid 14204322)
59. Gruber C. M. Jr, Mosier J. M., Grant P. et al. Objective comparison of phenobarbital and diphenylhydantoin in epileptic patients. Neurology: 1956; 6 640 645
60. Neubauer B. A. The mechanism of action is important for a rational AED therapy!-pro. Abstracts, 50. Jahrestagung der Deutschen Gesellschaft für Epileptologie. Wiesbaden, 28.4.-1.5.2010 S73 S74
61. Yahr M. D., Sciarra D., Carter S. Evaluation of standard anticonvulsant therapy of 319 patients. J Am Med Assoc: 1952; 150 663 667
62. Dean J. C., Penry J. K. Valproate monotherapy in 30 patients with partial seizures. Epilepsia: 1988; 29 140 144 (Pubitemid 18094822)
63. Walker J. E., Koon R. Carbamazepine versus valproate versus combined therapy for refractory partial complex seizures with secondary generalization. Epilepsia: 1988; 29 693
64. French J. A., Faught E. Rational polytherapy. Epilepsia: 2009; 50 08 63 68
65. Luszczki J. J., Swiader M., Parada-Turska J. et al. Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice. Neuropsychopharmacology: 2003; 28 1817 1830 (Pubitemid 41070847)
66. Lee J. W., Dworetzky B. Rational polytherapy with antiepileptic drugs. Pharmaceuticals: 2010; 3 2362 2379
67. Johannessen Landmark C., Patsalos P. N. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother: 2010; 10 119 140
68. Boon P. AJM. Antiepileptic drug treatment 2011; current limitations and future perspectives. Seizure: 2011; 20 357 358
69. Mattson R. H. Combination therapy with antiepileptic drugs: potential advantages and problems. In: Majkowski J., Bourgeois B., Patsalos P. N. et al. (eds) Antiepileptic drugs - combination therapy and interactions. Cambridge Cambridge University Press: 2005; 16 25
70. Homan R. W. Adjunctive and combination therapy. Engel J., Pedley T. A. (eds) Epilepsy: a comprehensive textbook. Philadelphia Lippincott-Raven: 1997; 1265 1275
71. Fontes Ribeiro C. A. Future research: a clinical perspective. In: Majkowski J., Bourgeois B., Patsalos P. N. et al. (eds) Antiepileptic drugs - combination therapy and interactions. Cambridge Cambridge University Press: 2005; 458 473
72. Fröscher W., Fiaux A., Rothmeier J. et al. Combination of lamotrigine with gamma-vinyl-GABA (Vigabatrin) in the management of intractable seizures. Epilepsia: 1993; 34 02 158
73. Schapel G. J., Black A. B., Lam E. L. et al. Combination vigabatrin and lamotrigine therapy for intractable epilepsy. Seizure: 1996; 5 51 56 (Pubitemid 26116081)
74. Guimaraes J., Mendes Ribeiro J. A. Pharmacology of antiepileptic drugs in clinical practice. The Neurologist: 2010; 16 353 357
75. Perucca E., Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol: 2011; 10 446 456
76. Brodie M. The place of polytherapy. Epilepsia: 2009; 50 04 27
77. Brodie M. J. Antiepileptic drug therapy the story so far. Seizure: 2010; 19 650 655
78. Cereghino J. J., Brock J. T., van Meter J. C. et al. The efficacy of carbamazepine combinations in epilepsy. Clin Pharmacol Ther: 1975; 18 733 741
79. Krämer G., Heinzl S. Lacosamid. 2. Aufl Stuttgart Ligatur: 2010
80. Sake J. K., Hebert D., Isojärvi J. et al. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs. CNS Drugs: 2010; 24 1055 1068
81. Chung S., Ben-Menachem E., Sperling M. R. et al. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials. CNS Drugs: 2010; 24 1041 1051
82. Brodie M. J., Rosenfeld W. E., Vazquez B. et al. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial. Epilepsia: 2009; 50 1899 1909
83. Frey M., Denny M., Zielinski D. et al. To evaluate the tolerability of lacosamide as add-on therapy to either non-sodium channel blocking or traditional sodium channel blocking anticonvulsant agents. Neurology: 2011; 76 04 A617
84. Kelly K., Stephen L. J., Parker P. et al. Adjunctive lacosamide for partial-onset seizures: preliminary outcomes from an epilepsy clinic. Epilepsia: 2011; 52 06 253
85. Kurth C., Steinhoff B. J. Langzeitbehandlung mit Lacosamid - Erfahrungen der Erwachsenenklinik des Epilepsiezentrums Kork. Abstract O 17. Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Sektionen der Int. Liga gegen Epilepsie. Graz 1.- 4. 6. 2011
86. Barcs G., Walker E. B., Elger C. E. et al. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia: 2000; 41 1597 1607 (Pubitemid 32002734)
87. Almas M., Budhwani M., Giordano S. et al. The use of cluster analysis to identify efficacious combinations of pregabalin and antiepileptic drugs for the treatment of partial-onset seizures. Neurology: 2011; 76 04 A615
88. Leach J. P., Brodie M. J. Synergism with GABAergic drugs in refractory epilepsy (letter). Lancet: 1994; 343 1650 (Pubitemid 24194842)
89. Bourgeois B. FD. Klinische Pharmakologie der im Handel befindlichen Antiepileptika. In: Fröscher W., Vassella F., Hufnagel A. (Hrsg). Die Epilepsien. 2. Aufl Stuttgart Schattauer: 2004; 546 563
90. Stephen L. J., Brodie M. J. Seizure freedom with more than one antiepileptic drug. Seizure: 2002; 11 349 351 (Pubitemid 35154146)
91. Czuczwar S. J., Kaplanski J., Swiderska-Dziewit G. et al. Pharmacodynamic interactions between antiepileptic drugs: preclinical data based on isobolography. Expert Opin Drug Metab Toxicol: 2009; 5 131 136
92. Jonker D. M., Voskuyl R. A., Danhof M. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments. Epilepsia: 2007; 48 412 434 (Pubitemid 46365183)
93. Kaminski R. M., Matagne A., Patsalos P. N. et al. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam. Epilepsia: 2009; 50 387 397
94. Elger C. E. Praktische Aspekte der Kombinationstherapie. Vortrag, Satellitensymposium Epilepsie und Schmerz: Eine individuelle Therapie ist nötig". 83. Jahrestagung der Dtsch. Gesellschaft für Neurologie. Mannheim: 23 09 2010
95. Brodie M. J., Kwan P. Staged approach to epilepsy management. Neurology: 2002; 58 05 S2 S8 (Pubitemid 34415365)
96. Richens A. Rational polypharmacy. Seizure: 1995; 4 211 214
97. Hvidberg E. F. Active metabolites in antiepileptic therapy. Reflections on a pharmacological joker. Acta Neurol Scand: 1983; 67 94 9 13 (Pubitemid 13057421)
98. Trobalt® Fachinformation. München Glaxo Smith Kline GmbH März 2011
99. Leppik I. E., Wolff D. L. Antiepileptic medication interactions. Neurol Clin: 1993; 11 905 921 (Pubitemid 23352629)
100. Perucca E. Rational polypharmacy, exploiting pharmacodynamic interactions for clinical benefit. Epilepsia: 2004; 45 03 36
101. Bourgeois B. FD, Gilliam F. Adjunctive and combination therapy. In: Engel J. Jr, Pedley T. A. (eds) Epilepsy - A comprehensive textbook. Vol. 2, 2nd ed Philadelphia Lippincott Williams and Wilkins: 2008; 1321 1325
102. Nicolson A., Marson A. G. When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy. Pract Neurol: 2010; 10 208 218
103. Welty T., Elgavish R., Faught E. et al. Identification of potentially effective antiepileptic drug combinations in patients with epilepsy. Epilepsia: 2009; 50 11 94
104. Fröscher W., Stoll K. D., Hoffmann F. Kombinationsbehandlung mit Carbamazepin und Valproinsäure bei Problemfällen einer Epilepsie-Ambulanz. Arzneimittelforsch: 1984; 34 910 914 (Pubitemid 14099920)
105. Harden C. L., Zisfein J., Atos-Radzion E. C. et al. Combination valproate-carbamazepine therapy in partial epilepsy resistant to carbamazepine monotherapy. Epilepsia: 1991; 32 19 20
106. Karceski S., Morrell M. J., Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav: 2005; 7 01 S1 S64 (Pubitemid 41131320)
107. Brainin M., Barnes M., Baron J. C. et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations. Europ J Neurol: 2004; 11 577 581 (Pubitemid 39279947)
108. Kugler S. L., Sachdeo E. C., Wenger E. C. et al. Efficacy of combination topiramate and lamotrigine in refractory epilepsy in children. Epilepsia: 1997; 38 08 192 193
109. Machado V. H., Palmini A., Bastos F. A. et al. Long-term control of epileptic drop attacks with the combination of valproate, lamotrigine, and a benzodiazepine: A "proof of concepto", open label study. Epilepsia: 2011; 52 1303 1310
110. Peltola J., Peltola M., Raitanen J. et al. Seizure-freedom with combination therapy in localization-related epilepsy. Seizure: 2008; 17 276 280 (Pubitemid 351324160)
111. Desai J., Mitchell W. G. Does one more medication help? Effect of adding another anticonvulsant in childhood epilepsy. J Child Neurol: 2011; 26 329 333
112. Stephen L. J., Forsyth M., Kelly K. et al. Seizure freedom on more than one antiepileptic drug. Epilepsia: 2011; 52 06 254
113. Wolf P. Scheinbare Pharmakoresistenz bei Epilepsie. Dtsch med Wschr: 1991; 116 606 610
114. Manohar C., Avitsian R., Lozano S. et al. The effect of antiepileptic drugs on coagulation and bleeding in the perioperative period of epilepsy surgery: The Childhood Clinic experience. J Clin Neurosci: 2011; 18 1180 1184
115. Stefan H., Fröscher W., Krämer G. et al. Pharmakotherapie vor und nach epilepsiechirurgischen Eingriffen. Nervenarzt: 2000; 71 451 458 (Pubitemid 30434513)
116. Lyczkowski D. A., Pfeifer H. H., Ghosh S. et al. Safety and tolerability of the ketogenic diet in pediatric epilepsy: Effects of valproate combination therapy. Epilepsia: 2005; 46 1533 1538
117. Ballaban-Gil K., Callahan C., O'Dell C. et al. Complications of the ketogenic diet. Epilepsia: 1998; 39 744 748 (Pubitemid 28319511)
118. Mulligan J. E., Mandelbaum D. E. Myoclonic astatic epilepsy and the role of the ketogenic diet. Med Health RI: 2011; 94 127 129
119. Veggiotti P., Burlina A., Coppola G. et al. The ketogenic diet for Dravet syndrome and other epileptic encephalopathies: an Italian consensus. Epilepsia: 2011; 52 02 83 89
120. Lee P. R., Kossoff E. H. Dietary treatments for epilepsy: Management guidelines for the general practitioner. Epilepsy Behav: 2011; 21 115 121
121. Baulac M. Rational conversion from antiepileptic polytherapy to monotherapy. Epileptic Disord: 2003; 5 125 132 (Pubitemid 37462293)
122. Bourgeois B. FD. Pharmacodynamic principles and mechanisms of drug interactions. In: Majkowski J., Bourgeois B., Patsalos P. N. et al. (eds) Antiepileptic drugs - combination therapy and interactions. Cambridge Cambridge University Press: 2005; 181 192
123. Carpay J. A., Aldenkamp P., van Donselaar C. A. Complaints associated with the use of antiepileptic drugs: Results from a community-based study. Seizure: 2005; 14 198 206 (Pubitemid 40425269)
124. Fröscher W., Krämer G., Schmidt D. et al. Empfehlungen zur medikamentösen Epilepsietherapie bei Jugendlichen und Erwachsenen. Akt Neurol: 2001; 28 460 467 (Pubitemid 34073279)
125. Fröscher W., Neher K. D. Kombinationstherapie bei Epilepsien. Epilepsie-Blätter: 1992; 5 69 78
126. Müller I., Elger C. E., von Wrede R. Social aspects in epilepsy: Educational, employment and retirement situation in patients with epilepsy. Epilepsia: 2009; 50 06 43 44
127. Thomas S. V., Koshy S., Sudhakaran Nair C. R. et al. Frequent seizures and polytherapy can impair quality of life in persons with epilepsy. Neurol India: 2005; 53 46 50 (Pubitemid 40545196)
128. Vajda F. JE, Hitchcock A. A., O'Brien T. J. et al. The teratogenic risk of antiepileptic drug therapy. Epilepsia: 2010; 51 805 810
129. Yorns W., Khurana D., Carvalho K. et al. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy. Neurology: 2011; 76 04 A615
130. Fröscher W., Hoffmann F. Komatöses Zustandsbild bei Behandlung mit einer Valproinsäure-Phenobarbital-Kombination. Nervenarzt: 1982; 53 484
131. Besag F. M., Wallace S. J., Dulac O. et al. Lamotrigine for the treatment of epilepsy in childhood. J Pediatr: 1995; 127 991 997 (Pubitemid 26003300)
132. Dong X., Leppik I. E., White J. et al. Hyponatremia from oxcarbazepine and carbamazepine. Neurology: 2005; 65 1976 1978 (Pubitemid 43970125)
133. Coppola G., Epifanio G., Auricchio G. et al. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Brain Dev: 2006; 28 358 365
134. Harden C. L., Meador K. J., Pennell P. B. et al. Practice parameter update: Management issues for women with epilepsy - focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes. Neurology: 2009; 73 133 141
135. Wandschneider B., Gaus V., Schmitz B. Fehlbildungsrisiko bei Antiepileptika. Nervenheilkunde: 2010; 29 199 203
136. Sukumaran S. C., Sarma P. S., Thomas S. V. Polytherapy increases the risk of infertility in women with epilepsy. Neurology: 2010; 75 1351 1355
137. Deckers C. LP, Hekster Y. A., Keyser A. et al. Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study. Epilepsia: 2001; 42 1387 1394 (Pubitemid 33140612)
138. Mattson R. H., Cramer J. A., Collins J. F. et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med: 1985; 313 145 151 (Pubitemid 15047456)
139. Aldenkamp A. P., de Krom M., Kotsopoulos I. et al. Cognitive side-effects due to antiepileptic drug combinations and interactions. In: Majkowski J., Bourgeois B., Patsalos P. N. et al. (eds) Antiepileptic drugs - combination therapy and interactions. Cambridge Cambridge University Press: 2005; 403 408
140. Mula M., Trimble M. R. Antiepileptic drug-induced cognitive adverse effects: Potential mechanisms and contributing factors. CNS Drugs: 2009; 23 121 137
141. Rösche J., Schley A., Benecke R. Neuropsychologisches Screening in einer epileptologischen Spezialsprechstunde - Ergebnisse und klinische Bedeutung. Nervenheilkunde: 2012; 31 in press
142. Canevini M. P., De Sarro G., Galimberti C. A. et al. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia: 2010; 51 797 804
143. Rösche J., Kundt G., Weber R. et al. The impact of antiepileptic polytherapy and cognitive function. Acta Neurol Belg: 2011; 111 29 32
144. Diener H. C., Putzki N., Berlit P. et al. Leitlinien für Diagnostik und Therapie in der Neurologie. 4. Aufl Stuttgart Thieme: 2008
145. Beghi E., Gatti G., Tonini C. et al. Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial. Epilepsy Res: 2003; 57 1 13 (Pubitemid 38045463)
146. Schmidt D. Drug treatment of epilepsy: Options and limitations. Epilepsy Behav: 2009; 15 56 65
147. Fröscher W. Allgemeine Behandlungsrichtlinien. In: Fröscher W., Vassella F., Hufnagel A. (Hrsg) Die Epilepsien. 2.Aufl Stuttgart Schattauer: 2004; 495 498
148. Naritoku D. K., Hulihan J. F., Kraut Schwarzman L. et al. Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: A randomized controlled trial. Ann Pharmacother: 2005; 39 418 423 (Pubitemid 40270907)
149. Wolf P. Acute administration of benzodiazepines as part of treatment strategies for epilepsy. CNS Neurosci Ther: 2011; 17 214 220. Epub2010Apr 8 10.1111/j.1755-5949.2010.00139.x
150. Wolf K. Epilepsietherapie praxisnah - Das Therapiepotenzial frühzeitig nutzen. Nervenheilkunde: 2011; 30 728 729
151. Löscher W., Schmidt D. Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma. Epilepsia: 2011; 52 657 678
152. Zacharias A., Seeck M. Update on novel antiepileptic drugs. Schweiz Arch Neurol Psychiat: 2011; 162 93 101
153. Kwan P., Schachter S. C., Brodie M. J. Drug-resistant epilepsy. N Engl J Med: 2011; 365 919 926
154. Fröscher W., Keller F., Vogt H. et al. Prospective study on concentration-efficacy and concentration-toxicity: Correlations with lamotrigine serum levels. Epileptic Disord: 2002; 4 49 55 (Pubitemid 34309263)
155. Tudur Smith C., Marson A. G., Clough H. E. et al. Carbamazepine versus phenytoin monotherapy for epilepsy. Cochrane Epilepsy Group Published online: 17 Mar 2010. DOI: 10.1002/14651858.CD001911
156. Lathers C. M., Schraeder P. L., Claycamp H. G. Clinical pharmacology of topiramate versus lamotrigine versus phenobarbital: comparison of efficacy and side effects using odds ratios. J Ciln Pharmacol: 2003; 43 491 503 (Pubitemid 36506150)
157. Glauser T. A., Cnaan A., Shinnar S. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med: 2010; 362 790 799
158. Fröscher W., Auner M., Kirschbaum J. Behandlungsergebnisse bei pharmakoresistent erscheinenden Epilepsie-Patienten. Akt Neurol: 1989; 16 1 8 (Pubitemid 19060954)
159. Stephen L. J., Forsyth M., Kelly K. et al. Antiepileptic drug combinations-Have newer agents altered clinical outcomes? Epilepsy Res: 2011; 10.1016/j.epilepsyres.2011.09.008